ID   EPG85-257DAU
AC   CVCL_X177
SY   257DAU
DR   Wikidata; Q54832363
RX   PubMed=7773504;
RX   PubMed=9180151;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X333 ! EPG85-257P
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 7
//
RX   PubMed=7773504; DOI=10.1007/BF00191362;
RA   Seidel A., Hasmann M., Loser R., Bunge A., Schaefer B., Herzig I.,
RA   Steidtmann K., Dietel M.;
RT   "Intracellular localization, vesicular accumulation and kinetics of
RT   daunorubicin in sensitive and multidrug-resistant gastric carcinoma
RT   EPG85-257 cells.";
RL   Virchows Arch. 426:249-256(1995).
//
RX   PubMed=9180151; DOI=10.1002/(SICI)1097-0215(19970529)71:5<817::AID-IJC20>3.0.CO;2-3;
RA   Kellner U., Hutchinson L., Seidel A., Lage H., Danks M.K., Dietel M.,
RA   Kaufmann S.H.;
RT   "Decreased drug accumulation in a mitoxantrone-resistant gastric
RT   carcinoma cell line in the absence of P-glycoprotein.";
RL   Int. J. Cancer 71:817-824(1997).
//